Grail News and Activities

Presence

Grail develops blood-based cancer screening and early detection services. Its products help healthcare providers, health systems, and employers identify cancer signals in people without symptoms.

Grail products and services overview:

Cancer screening tests
Blood diagnostic tests
Early detection services
Laboratory testing services

Revenue: ~$130 million

Employees: 900

Headquarters: Menlo Park, United States (USA)

Grail is owned by Illumina.

Illumina is one of the...

Illumina is a company listed under the stock ticker ILMN (US).

Illumina has 4 subsidiaries including Grail, Illumina Ventures and PacBio.

They are in:

Acquisition, funding and merger involving Illumina.

Illumina has acquired SomaLogic (posted on January 30 2026).
Illumina has announced the acquisition of SomaLogic (posted on June 23 2025).

Executives

View the org chart displaying its 25 main executives

Most searched biographies at Grail

Popular executive movements at Grail

Bob Ragusa, Chief Executive Officer and Director, will leave the company on Jun. 1, 2026 (posted on March 13 2026).
Joshua Ofman who is President, will be promoted to Chief Executive Officer on Jun. 1, 2026 (posted on March 13 2026).

Popular executive movements at Illumina

Mike Sullivan will join the company as Chief Commercial Officer on Jul. 20, 2026 (posted on July 10 2026).
Julie Coletti will join the company as Chief Legal Officer on Aug. 3, 2026 (posted on July 10 2026).
Daniel Skovronsky has joined the company as Director (posted on June 24 2026).

Click here to view some more movements at Illumina

Create your alert
to follow the executive moves at Grail.

Biotechnology

Illumina has 2,424 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

The new name of EG 427 is Cyllene Therapeutics. (posted on July 10 2026).
Opthea will change its company name to Ceryvyn Therapeutics on Jul 9, 2026. (posted on July 9 2026).
Tissium has just announced a $60 Million fundraising (posted on July 8 2026).